{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,26]],"date-time":"2025-09-26T00:20:15Z","timestamp":1758846015642,"version":"3.44.0"},"reference-count":9,"publisher":"BMJ","issue":"11","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Clin Pathol"],"published-print":{"date-parts":[[1990,11]]},"abstract":"<jats:p>Bone marrow smears from 15 patients with multiple myeloma, 15 patients with monoclonal gammopathy of undetermined significance (MGUS), and 15 control subjects were examined for the presence of cytoplasmic 5'nucleotidase (c5NT) in plasma cells. Plasma cell positivity for c5NT (mean and 95% confidence interval) in patients with multiple myeloma numbered 46.4% (38.0-54.8%), in those with MGUS it was 15.3% (11.1-19.6%), and in control subjects it was 1.2% (0.3-2.1%). These findings indicate that c5NT can be used to differentiate benign from malignant monoclonal gammopathies.<\/jats:p>","DOI":"10.1136\/jcp.43.11.891","type":"journal-article","created":{"date-parts":[[2007,6,9]],"date-time":"2007-06-09T00:50:46Z","timestamp":1181350246000},"page":"891-892","source":"Crossref","is-referenced-by-count":1,"title":["Use of cytoplasmic 5'nucleotidase for differentiating malignant from benign monoclonal gammopathies."],"prefix":"10.1136","volume":"43","author":[{"given":"G","family":"Majumdar","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S E","family":"Heard","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A K","family":"Singh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"239","published-online":{"date-parts":[[1990,11,1]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1111\/j.1365-2257.1983.tb01363.x","article-title":"5'nucleotidase activity in myeloma cells","volume":"5","author":"EA, El Mohandes; FGJ, Hayhoe","year":"1983","unstructured":"El Mohandes EA, Hayhoe FGJ. 5'nucleotidase activity in myeloma cells. Clin Lab Haematol 1983;5:265-9.","journal-title":"Clin Lab Haematol"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1007\/BF01002894","article-title":"Cytochemistry of the acute leukaemias","volume":"16","author":"Hayhoe, F.G.J.","year":"1984","unstructured":"Hayhoe FGJ. Cytochemistry of the acute leukaemias. Histochem J 1984;16:1051-9.","journal-title":"Histochem J"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1136\/jcp.40.7.793","article-title":"Laboratory investigation ofmonoclonal gammopathy during 10 years of screening in a general hospital","volume":"40","author":"Malacrida, V.; De Francesco, D.; Banfi, G.; Porta, F.A.; Riches, P.G.","year":"1987","unstructured":"Malacrida V, De Francesco D, Banfi G, Porta FA, Riches PG. Laboratory investigation ofmonoclonal gammopathy during 10 years of screening in a general hospital. J Clin Pathol 1987;40:793-7.","journal-title":"J Clin Pathol"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1111\/j.1365-2141.1984.tb06116.x","article-title":"Low plasma cell 3(H)-thymidine incorporation in monoclonal gammopathy of undetermined significance (MGUS), smouldering myeloma and remission phase myeloma: a reliable indicator of patients not requiring therapy","volume":"58","author":"Boccadoro, M.; Gavarotti, P.; Fossati, G.; Pileri, A.; Marmont, F.; Neretto, G.","year":"1984","unstructured":"Boccadoro M, Gavarotti P, Fossati G, Pileri A, Marmont F, Neretto G. Low plasma cell 3(H)-thymidine incorporation in monoclonal gammopathy of undetermined significance (MGUS), smouldering myeloma and remission phase myeloma: a reliable indicator of patients not requiring therapy. Br J Haematol 1984;58:689-96.","journal-title":"Br J Haematol"},{"key":"ref_5","first-page":"969","article-title":"Immunofluorescence labelling indices in myeloma and related monoclonal gammopathies","volume-title":"Mayo Clin Proc","volume":"62","author":"Greipp, P.R.; Witzig, T.E.; Gonchoroff, N.J.","year":"1987","unstructured":"Greipp PR, Witzig TE, Gonchoroff NJ, et al. Immunofluorescence labelling indices in myeloma and related monoclonal gammopathies. Mayo Clin Proc 1987;62: 969-77."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1159\/000207709","article-title":"Differentiation between benign and malignant monoclonal gammopathies by discriminant analysis on serum and bone marrow parameters","volume":"60","author":"Morell, A.; Maurer, W.; Skvaril, F.; Barandun, S.","year":"1978","unstructured":"Morell A, Maurer W, Skvaril F, Barandun S. Differentiation between benign and malignant monoclonal gammopathies by discriminant analysis on serum and bone marrow parameters. Acta Haematol 1978;60:129-36.","journal-title":"Acta Haematol"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1111\/j.1365-2141.1985.tb02964.x","article-title":"Plasma cell acid phosphatase score in multiple myeloma and related disorders","volume":"59","author":"Hoffmann, J.J.M.L.; Breed, W.P.M.; Swaak-Lammers, N.","year":"1985","unstructured":"Hoffmann JJML, Breed WPM, Swaak-Lammers N. Plasma cell acid phosphatase score in multiple myeloma and related disorders. Br J Haematol 1985;59:67-72.","journal-title":"Br J Haematol"},{"key":"ref_8","first-page":"432","article-title":"Haematological cytochemistry","author":"Quaglino, D.; Hayhoe, F.G.J.","year":"1988","unstructured":"Quaglino D, Hayhoe FGJ. Haematological cytochemistry. 2nd edition. Edinburgh: Churchill Livingstone, 1988: 432-3.","edition":"2nd edition"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"1849","DOI":"10.1001\/jama.1984.03340380031018","article-title":"Benign monoclonal gammopathy: a misnomer?","volume":"251","author":"Kyle, R.A.","year":"1984","unstructured":"Kyle RA. Benign monoclonal gammopathy: a misnomer? JAMA 1984;251:1849-54.","journal-title":"JAMA"}],"container-title":["Journal of Clinical Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/jcp.43.11.891","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,25]],"date-time":"2025-09-25T16:10:32Z","timestamp":1758816632000},"score":1,"resource":{"primary":{"URL":"https:\/\/jcp.bmj.com\/lookup\/doi\/10.1136\/jcp.43.11.891"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1990,11]]},"references-count":9,"journal-issue":{"issue":"11","published-online":{"date-parts":[[1990,11,1]]},"published-print":{"date-parts":[[1990,11]]}},"alternative-id":["10.1136\/jcp.43.11.891"],"URL":"https:\/\/doi.org\/10.1136\/jcp.43.11.891","relation":{},"ISSN":["0021-9746","1472-4146"],"issn-type":[{"type":"print","value":"0021-9746"},{"type":"electronic","value":"1472-4146"}],"subject":[],"published":{"date-parts":[[1990,11]]}}}